| Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||||
Net income | ||||||||
53,629 | 3,990 | 89,961 | -12,458 | -65,664 | -122,217 | -12,309 | -6,532 | 2,609 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Gain on sale of equity method investment | ||||||||
- | - | - | - | 385 | 5,156 | 0 | - | - |
Gain on sale of discontinued operations, net of tax | ||||||||
- | - | - | - | - | - | 200 | 125 | 808 |
Loss from debt extinguishment | ||||||||
- | - | - | -1,249 | -13,424 | -39,331 | -3,806 | - | - |
Gain on sale of equity method investment | ||||||||
- | - | - | - | - | - | - | 0 | - |
Loss from debt extinguishment | ||||||||
- | - | - | - | - | - | - | 0 | - |
Depreciation and amortization | ||||||||
71,544 | 78,048 | 56,345 | 74,779 | 79,844 | 78,981 | 29,456 | 15,724 | - |
Depreciation and amortization | ||||||||
- | - | - | - | - | - | - | - | 13,295 |
Stock based compensation | ||||||||
23,201 | 20,714 | 20,064 | 19,567 | 18,502 | 11,927 | 6,933 | 4,711 | 4,898 |
Deferred income taxes | ||||||||
-2,287 | 7,714 | -50,242 | 20,244 | 20,869 | -17,829 | -50,112 | -12,274 | -1,672 |
Amortization of debt issuance costs and other | ||||||||
15,321 | 14,015 | 11,392 | - | - | - | - | - | - |
Amortization of debt issuance costs and other | ||||||||
- | - | - | 10,932 | 5,567 | 11,420 | 2,766 | - | - |
Asset impairment | ||||||||
291 | 9,091 | 0 | 2,040 | 0 | 0 | - | - | - |
Amortization of debt issuance costs | ||||||||
- | - | - | - | - | - | - | 578 | 2 |
Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | ||||||||
4,390 | 3,056 | -4,000 | -821 | 815 | 1,906 | 407 | -389 | -1,065 |
Prepaid expenses and other assets | ||||||||
1,574 | 2,515 | -1,937 | 2,255 | 5,313 | 3,020 | -1,711 | -2,272 | 1,084 |
Deferred expenses | ||||||||
-228 | -170 | -4,206 | -5,610 | -3,094 | -3,004 | -2,025 | 963 | - |
Accounts payable | ||||||||
2,690 | -1,388 | -489 | -2,739 | 4,521 | 295 | -1,509 | 1,010 | -526 |
Accrued expenses and other liabilities | ||||||||
2,574 | -1,473 | -792 | 1,394 | 2,183 | -4,105 | 1,694 | -3,103 | -1,554 |
Accrued compensation and benefits | ||||||||
-3,415 | -406 | 8,065 | -7,788 | -1,990 | -577 | -2,897 | 3,492 | 1,652 |
Accrued restructuring costs | ||||||||
- | - | - | -1,139 | -338 | -4,176 | 5,199 | -585 | -1,586 |
Deferred revenue | ||||||||
-7,992 | 7,961 | 7,986 | 6,949 | 28,961 | 91,993 | 28,768 | 11,157 | -1,995 |
Net cash provided by operating activities | ||||||||
149,820 | 132,865 | 152,433 | 117,206 | 102,460 | 77,965 | 14,924 | 15,751 | 14,296 |
Cash flows from investing activities | ||||||||
Business acquisitions, net of cash acquired | ||||||||
17,275 | 303,262 | 1,330 | 19,246 | 0 | 0 | 405,120 | 130,142 | 3,740 |
Proceeds from sale of discontinued operations | ||||||||
- | - | - | - | - | - | 325 | - | - |
Proceeds from sale of discontinued operations | ||||||||
- | - | - | - | - | - | - | 125 | - |
Proceeds from sale of discontinued operations | ||||||||
- | - | - | - | - | - | - | - | 808 |
Proceeds from sale of equity method investment | ||||||||
- | - | - | - | 385 | 7,197 | 0 | 0 | - |
Investment in intangible assets | ||||||||
- | - | - | - | - | - | - | 1,396 | 5 |
Capital expenditures | ||||||||
21,474 | 22,140 | 14,747 | 15,166 | 14,713 | 22,298 | 4,270 | 1,656 | 1,131 |
Other | ||||||||
0 | 1,551 | 0 | 0 | 50 | 76 | -83 | 0 | - |
Net cash used in investing activities | ||||||||
-38,749 | -326,953 | -16,077 | -34,412 | -14,378 | -15,177 | -408,982 | -133,069 | -4,068 |
Cash flows from financing activities | ||||||||
Stock issuance costs | ||||||||
22 | 27 | 104 | 98 | 43 | 21 | 16 | 14 | 19 |
Common stock repurchased | ||||||||
4,573 | 4,261 | 2,412 | 6,327 | 6,342 | 4,683 | 452 | - | 4,699 |
Payments of long-term debt | ||||||||
42,954 | 9,813 | 6,250 | 367,328 | 1,015,076 | 701,574 | 341,748 | 12,256 | 641 |
Payments of revolving credit facility | ||||||||
88,313 | 70,687 | 89,000 | - | - | - | - | - | - |
Proceeds from exercise of stock options | ||||||||
15,701 | 4,970 | 7,952 | 9,899 | 14,164 | 5,822 | 9,073 | 1,839 | 1,410 |
Deferred consideration payment | ||||||||
20,433 | 0 | 0 | - | - | - | - | - | - |
Common stock repurchased | ||||||||
- | - | - | - | - | - | - | 53 | - |
Stock options repurchased | ||||||||
- | - | - | - | - | - | - | - | 979 |
Proceeds from borrowings on long-term debt | ||||||||
50,000 | 200,000 | 0 | 192,020 | 910,631 | 623,205 | 745,500 | 110,000 | - |
Proceeds from borrowings on revolving credit facility | ||||||||
49,000 | 115,000 | 0 | 112,208 | 10,000 | 20,000 | - | - | - |
Debt issuance costs | ||||||||
1,935 | 5,700 | 0 | 3,680 | 2,791 | 3,720 | 21,242 | 5,318 | - |
Common stock purchases under stock repurchase plan | ||||||||
76,278 | 28,565 | 50,617 | 10,785 | 0 | 0 | - | - | - |
Other | ||||||||
-129 | 0 | 0 | - | - | - | - | - | - |
Net cash used in financing activities | ||||||||
-119,936 | 200,917 | -140,431 | -74,091 | -89,457 | -60,971 | 391,115 | 94,198 | -4,928 |
Effect of exchange rate changes on cash | ||||||||
-22 | -63 | -2 | -24 | 0 | 0 | - | - | - |
Net increase in cash and cash equivalents | ||||||||
-8,887 | 6,766 | -4,077 | - | - | - | - | - | - |
Net (decrease) increase in cash and cash equivalents | ||||||||
- | - | - | 8,679 | -1,375 | 1,817 | -2,943 | -23,120 | 5,300 |
Supplemental cash flow information | ||||||||
Interest paid | ||||||||
17,562 | 15,764 | 8,761 | 17,303 | 35,047 | 57,293 | 14,364 | 2,605 | 47 |
Income taxes paid, net | ||||||||
4,406 | 3,590 | 2,076 | 1,134 | 499 | 252 | 1,089 | 287 | 296 |
Common stock options issued for acquisitions | ||||||||
0 | 2,340 | 0 | 0 | - | - | - | - | - |
Capital expenditures, tenant improvements funded by lessor | ||||||||
1,984 | 0 | 0 | - | - | - | - | - | - |
Deferred consideration from acquisitions | ||||||||
2,333 | 40,017 | 0 | 0 | - | - | - | - | - |
Acquisition-related note payable | ||||||||
- | - | - | - | - | - | - | 5,000 | - |